Growth factor helps diagnose ectopic pregnancy:
This article was originally published in Clinica
Executive Summary
Vascular endothelial growth factor (VEGF) could be used to diagnose ectopic pregnancy, according to a study carried out by researchers at Tel Aviv Sourasky Medical Centre in Israel. Progesterone and human chorionic gonadotrophin have both been used for this purpose, but neither is highly specific for ectopic pregnancy. Elevated VEGF levels had a sensitivity of 60% and a specificity of 90% for distinguishing extrauterine from interuterine pregnancies, the researchers report in Fertility and Sterility (December). Combining the VEGF measurement with serum progesterone levels enhanced the test's specificity to 95%.
You may also be interested in...
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.
CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales
Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.